Bromocriptine in peripartum cardiomyopathy: A meta‐analysis with trial sequential analysis

Abstract Bromocriptine has been proposed as a disease‐modifying therapy for peripartum cardiomyopathy (PPCM). The long‐term outcomes of bromocriptine use remain uncertain. We conducted a systematic review, meta‐analysis and trial sequential analysis (TSA) to assess the long‐term efficacy and safety...

詳細記述

書誌詳細

主要な著者:	Umar G. Adamu, Kabo Mojela, Kamilu M. Karaye, Nqoba Tsabedze
フォーマット:	Artigo
言語:	Inglês
出版事項:	Oxford University Press 2025-12-01
シリーズ:	ESC Heart Failure
主題:	bromocriptine long‐term outcomes peripartum cardiomyopathy standard of care trial sequential analysis
オンライン･アクセス:	https://doi.org/10.1002/ehf2.70003
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!